BHF (Life & Health Insurance) Stock Valuation & Fair Value Fairly valued
BHF (Life & Health Insurance) trades at a blended P/E of 2.8, about 36% below its historical normal valuation, with a forward growth estimate of -6.6% and a PEG of —. Analysts' one-year estimates have been hit 13% of the time.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.
Valuation flags
- Negative growth forecast
Frequently asked questions
Is BHF overvalued?
At a blended P/E of 2.8 versus its historical normal P/E of 4.3, BHF trades about 36% below its typical valuation. tickerseer currently rates it fairly valued.
What is BHF's fair value and PEG?
BHF trades at a blended P/E of 2.8 against a historical normal P/E of 4.3, and a forward growth estimate of -6.6%.
Has tickerseer's rating of BHF changed?
tickerseer's rating has been fairly valued since 2026-08-07.
Industry: Life & Health Insurance. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.